NORTH HOLLYWOOD, Calif., July 22, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – today announced publication of a new updated edition of Multiple Myeloma: A Textbook for Nurses, an invaluable resource for oncology nurses. The book, which provides in-depth knowledge on the specific needs of the myeloma patient, has been lauded as a text written specifically for nurses and also authored by nurses.
The lead authors and editors are Joseph Tariman, PhD, ANP-BC and Beth Faiman, PhD, APRN-BC, AOCN®, longtime members of the IMF’s Nurse Leadership Board.
The new edition focuses on nursing research and evidence-based care of patients with myeloma. In addition, the book now addresses advances in genomics and biomarkers and reviews the latest clinical breakthroughs.
The foreword by Margaret Frogge, RN, MSN and former editor of Cancer Nursing: Principles and Practice, cites Tariman and Faiman as “two well-recognized nurse experts” who have been crucial to “advancing the science and care of individuals with multiple myeloma.” The two editors have extensive experience in patient care, nursing and clinical trial research, and student and staff education. Both serve on national boards and panels addressing myeloma advances.
First published in 2010 by the Oncology Nursing Society Publishing Division, Multiple Myeloma: A Textbook for Nurses is a comprehensive review of myeloma, encompassing the history of the disease, nursing contributions to myeloma care, basic anatomy and physiology, the role genetics plays in patients with this disease, and incidence rates and risk factors.
ABOUT THE INTERNATIONAL MYELOMA FOUNDATION (IMF)
Established in 1990, the International Myeloma Foundation (IMF) is the oldest and largest foundation focusing specifically on multiple myeloma. The Foundation’s reach extends to more than 350,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure by focusing on four key areas: research, education, support, and advocacy. The IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned InfoLine, and in 2001, established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. In 2013, the IMF launched the Black Swan Research Initiative®, a groundbreaking effort to find a definitive cure for myeloma. The IMF can be reached at (800) 452-CURE (2873). The global website is www.myeloma.org. Follow the IMF on Twitter @IMFmyeloma.